Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Other Non-Current Liabilities: 2017-2025

Historic Other Non-Current Liabilities for Organogenesis Holdings (ORGO) over the last 7 years, with Sep 2025 value amounting to $2.5 million.

  • Organogenesis Holdings' Other Non-Current Liabilities rose 93.89% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 93.89%. This contributed to the annual value of $894,000 for FY2024, which is 26.30% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Other Non-Current Liabilities of $2.5 million as of Q3 2025, which was down 16.98% from $3.0 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Other Non-Current Liabilities peaked at $8.7 million during Q2 2021, and registered a low of $894,000 during Q4 2024.
  • In the last 3 years, Organogenesis Holdings' Other Non-Current Liabilities had a median value of $1.2 million in 2023 and averaged $1.4 million.
  • In the last 5 years, Organogenesis Holdings' Other Non-Current Liabilities tumbled by 87.62% in 2022 and then soared by 138.33% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Other Non-Current Liabilities (Quarterly) stood at $1.6 million in 2021, then declined by 27.94% to $1.1 million in 2022, then increased by 8.11% to $1.2 million in 2023, then declined by 26.30% to $894,000 in 2024, then soared by 93.89% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q3 2025, $3.0 million for Q2 2025, and $897,000 during Q1 2025.